Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
Announcements
Projects
Orgs
Project
Post
Articles 201
Votes 10
30% interested
Seeking Alpha
Home
Members
Articles
Authors
111
Adam Levine-Weinberg CFA
Marc Chandler
Ishwarya Prasanna
Daniel Thurecht
Brad Thomas
John Vincent
Timothy D Gallagher
Daniel Schönberger
Edgar Torres H
Stone Fox Capital
Carlton Getz
CFA
Carlton Getz
CFA
Clark Schultz
Clark Schultz
Fun Trading
Liz Kiesche
SA Transcripts
The Insiders Forum
Simple Investment Ideas
Danielle Park
D.M. Martins Research
Dean Young
Ryan Telford
Thomas J. Hayes
Trading Places Research
Steven Bavaria
Gold Mining Bull
Chris Ciaccia
Ravikash
Growth at a Good Price
Busted IPO Forum
Eric Sprague
Gaurav Batavia
Kim Khan
Kevin P. Curran
Joshua Fineman
Mott Capital Management
Max Gottlich
Tradevestor
Dan Stringer
Manuel Paul Dipold
Dhierin Bechai
JP Research
John M. Mason
Dylan Waller
Simple Investing
Blue Harbinger
Stuart Allsopp
Gold Panda
Juxtaposed Ideas
Alpha Investment Research
Karreta Advisors
Lane Simonian
Rex Crum
Liang Zhao
Ironside Research
Anuron Mitra
Chetan Woodun
Mary Christine Joy
Dan Victor
Meghavi Singh
Deep Tech Insights
Felix Fung
Jason Aycock
Niloofer Shaikh
Yiannis Zourmpanos
Khyathi Dalal
The Asian Investor
David H. Lerner
Pranav Ghumatkar
Financially Free Investor
Dulan Lokuwithana
Daniel Jones
Ordinary Wealth
Cavenagh Research
Deepa Sarvaiya
Yoel Minkoff
Jonathan Block
Vladimir Dimitrov
Zen Analyst
Early Retiree
Quad 7 Capital
Steven Cress
Atlas Equity Research
Dividend Sensei
JR Research
Bradley Guichard
Jessica Kuruthukulangara
Victor Dergunov
Rob Williams NY
Vlad Deshkovich
Carl Surran
Michael James McDonald
Logan Kane
Johnny Zhang
Rida Morwa
SA Editor Jeffrey Fischer
Bold Investor
High Yield Investor
SA Stocks To Watch
Ahmed Farhath
Joseph L. Shaefer
Christiana Sciaudone
Samuel Smith
Jason Capul
Leo Nelissen
Steven Fiorillo
Andrew McElroy
On the Pulse
«
Prev
1
2
3
4
5
6
7
8
…
Next
»
Sarepta stock jumps on FDA panel nod for gene therapy (NASDAQ:SRPT) - Seeking Alpha
~2y
CVS stock gains on plans to close clinical trial business (NYSE:CVS) - Seeking Alpha
~2y
Google: 2 Huge Q1 Items You May Have Missed (Hint: It's Not AI) (NASDAQ:GOOG) - Seeking Alpha
~2y
Inflation Expectations Are On The Cusp Of Becoming Unanchored - Seeking Alpha
~2y
PayPal Stock: It Could Get Worse (NASDAQ:PYPL) - Seeking Alpha
~2y
Palantir: Successfully Commoditizing AI Tools (NYSE:PLTR) - Seeking Alpha
~2y
How To Invest $100000 Today: The Near-Perfect Portfolio Strategy - Seeking Alpha
~2y
Apple: Buffett's Favorite Company Just Changed The Game (AAPL) - Seeking Alpha
~2y
Petrobras Q1 Earnings: Strong Performance, Possible Buybacks (NYSE:PBR) - Seeking Alpha
~2y
Warren Buffett Warning to Bank Investors as Berkshire Hathaway Prepares for Impact (BRK.B) - Seeking Alpha
~2y
Palantir Earnings: SBC Slowdown And Real GAAP Profits (NYSE:PLTR) - Seeking Alpha
~2y
Berkshire Dumps Billions Worth Of U.S. Stocks, Buys Treasuries Instead (BRK.A) (BRK.B) - Seeking Alpha
~2y
Warren Buffett Says America's 'Incredible Period' Is Ending - Seeking Alpha
~2y
Block stock slips after Q1 beat, Cash App Card, inflows discussed on call (NYSE:SQ) - Seeking Alpha
~2y
AMD Stock: Game-Changing Rumors Fuel AI Comeback (NASDAQ:AMD) - Seeking Alpha
~2y
Microsoft And AMD Join Forces: New Era For AI Chip Market Competition - Seeking Alpha
~2y
Paramount Stock: Dividend Cut Creates Massive Value (NASDAQ:PARA) - Seeking Alpha
~2y
Smoking rates in US reach lowest level in nearly 60 years - Seeking Alpha
~2y
AMD: The Bear Market Rally Is Over (NASDAQ:AMD) - Seeking Alpha
~2y
Pfizer beats Q1 top and bottom line estimates; reaffirms FY23 outlook - Seeking Alpha
~2y
ON Semiconductor Non-GAAP EPS of $1.19 beats by $0.11, revenue of $1.96B beats by $30M (NASDAQ:ON) - Seeking Alpha
~2y
Charlie Munger sounds warning on U.S. commercial property market (NYSE:BRK.B) - Seeking Alpha
~2y
Google: Rally Incoming (NASDAQ:GOOG) - Seeking Alpha
~2y
Series I Bonds Offering A Whopping 0.9% Fixed Rate - Seeking Alpha
~2y
First Republic Bank: A Shrewd Move To Preserve Capital (NYSE:FRC) - Seeking Alpha
~2y
«
Prev
1
2
3
4
5
6
7
8
…
Next
»
Modal title
...
Profile
Loading profile
Loading...